Combination of antioxidant supplements improved cognitive function in the elderly

Journal of Alzheimer's Disease

Volumn 32, Issue 4, 2012, Pages 895-903

  Yasuno, Fumihiko ^a,b   Tanimukai, Satoshi ^a,d   Sasaki, Megumi ^a   Ikejima, Chiaki ^a   Yamashita, Fumio ^a,c   Kodama, Chiine ^a,c   Mizukami, Katsuyoshi ^a   Asada, Takashi ^a  

^a UNIVERSITY OF TSUKUBA   (Japan)

^b NARA MEDICAL UNIVERSITY   (Japan)

^c NATIONAL INSTITUTE OF MENTAL HEALTH   (Japan)

^d EHIME UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

Author keywords

Antioxidant; apolipoprotein E4 allele (APOE4); cognitive function; Ginkgo biloba extracts (GE); lycopene; n 3 polyunsaturated fatty acid (n 3 PUFA)

Indexed keywords

ANTIOXIDANT; APOLIPOPROTEIN E4; CHOLESTEROL; DOCOSAHEXAENOIC ACID; GINKGO BILOBA EXTRACT; ICOSAPENTAENOIC ACID; LOW DENSITY LIPOPROTEIN; LYCOPENE; OMEGA 3 FATTY ACID; TRIACYLGLYCEROL;

AGED; ANTIOXIDANT ACTIVITY; ARTICLE; BLOOD SAMPLING; COGNITION; CONTROLLED STUDY; DIABETES MELLITUS; DIETARY INTAKE; EFFECT SIZE; FEMALE; FISH; FOLLOW UP; GENOTYPE; HETEROZYGOTE; HUMAN; HYPERTENSION; MAJOR CLINICAL STUDY; MALE; MEMORY; PRIORITY JOURNAL; PROSPECTIVE STUDY;

EID: 84872361661     PISSN: 13872877     EISSN: 18758908     Source Type: Journal    
DOI: 10.3233/JAD-2012-121225     Document Type: Article

References (47)

1. MeydaniM(2001) Antioxidants and cognitive function. Nutr Rev 59, S75-S80.
2. Nunomura A, Castellani RJ, Zhu X, Moreira PI, Perry G, Smith MA (2006) Involvement of oxidative stress in Alzheimer disease. J Neuropathol Exp Neurol 65, 631-641.
3. Quinn JF, Raman R, Thomas RG, Yurko-Mauro K, Nelson EB, Van Dyck C, Galvin JE, Emond J, Jack CRJ, Weiner M, Shinto L, Aisen PS (2010) Docosahexaenoic acid supplementation and cognitive decline in Alzheimer disease: A randomized trial. JAMA 304, 1903-1911.
4. Rogers PJ, Appleton KM, Kessler D, Peters TJ, Gunnell D, Hayward RC, Heatherley SV, Christian LM, McNaughton SA, Ness AR (2008) No effect of n-3 long-chain polyunsaturated fatty acid (EPA and DHA) supplementation on depressed mood and cognitive function: A randomised controlled trial. Br J Nutr 99, 421-431.
5. Snitz BE, O'Meara ES, Carlson MC, Arnold AM, Ives DG, Rapp SR, Saxton J, Lopez OL, Dunn LO, Sink KM, DeKosky ST, Ginkgo Evaluation of Memory (GEM) Study Investigators (2009) Ginkgo biloba for preventing cognitive decline in older adults: A randomized trial. JAMA 302, 2663-2670.
6. Kang JH, Ascherio A, Grodstein F (2005) Fruit and vegetable consumption and cognitive decline in aging women. Ann Neurol 57, 713-720.
7. Morris MC, Evans DA, Tangney CC, Bienias JL, Wilson RS (2006) Associations of vegetable and fruit consumption with age-related cognitive change. Neurology 67, 1370-1376.
8. Connor WE (2000) Importance of n-3 fatty acids in health and disease. Am J Clin Nutr 71, 171S-175S.
9. Hashimoto M, Hossain S (2011) Neuroprotective and ameliorative actions of polyunsaturated fatty acids against neuronal diseases: Beneficial effect of docosahexaenoic acid on cognitive decline in Alzheimer's disease. J Pharmacol Sci 116, 150-162.
10. Conquer JA, Tierney MC, Zecevic J, Bettger WJ, Fisher RH (2000) Fatty acid analysis of blood plasma of patients with Alzheimer's disease, other types of dementia, and cognitive impairment. Lipids 35, 1305-1312.
11. Kuhad A, Sethi R, Chopra K (2008) Lycopene attenuates diabetes-associated cognitive decline in rats. Life Sci 83, 128-134.
12. DeFeudis FV, Drieu K (2000) Ginkgo biloba extract (EGb 761) and CNS functions: Basic studies and clinical applications. Curr Drug Targets 1, 25-58.
13. Ni Y, Zhao B, Hou J, Xin W (1996) Preventive effect of Ginkgo biloba extract on apoptosis in rat cerebellar neuronal cells induced by hydroxyl radicals. Neurosci Lett 214, 115-118.
14. Wei T, Ni Y, Hou J, Chen C, Zhao B, XinW(2000) Hydrogen peroxide-induced oxidative damage and apoptosis in cerebellar granule cells: Protection by Ginkgo biloba extract. Pharmacol Res 41, 427-433.
15. Kaschel R (2009) Ginkgo biloba: Specificity of neuropsychological improvement-a selective review in search of differential effects. Hum Psychopharmacol 24, 345-370.
16. Le Bars PL, Katz MM, Berman N, Itil TM, Freedman AM, Schatzberg AF (1997) A placebo-controlled, double-blind, randomized trial of an extract of Ginkgo biloba for dementia. North American EGb Study Group. JAMA 278, 1327-1332.
17. Mix JA, Crews WDJ (2002) A double-blind, placebocontrolled, randomized trial of Ginkgo biloba extract EGb 761 in a sample of cognitively intact older adults: Neuropsychological findings. Hum Psychopharmacol 17, 267-277.
18. Solomon PR, Adams F, Silver A, Zimmer J, DeVeaux R (2002) Ginkgo for memory enhancement: A randomized controlled trial. JAMA 288, 835-840.
19. Canter PH, Ernst E (2007) Ginkgo biloba is not a smart drug: An updated systematic review of randomised clinical trials testing the nootropic effects of G. biloba extracts in healthy people. Hum Psychopharmacol 22, 265-278.
20. Davignon J, Cohn JS, Mabile L, Bernier L (1999) Apolipoprotein E and atherosclerosis: Insight from animal and human studies. Clin Chim Acta 286, 115-143.
21. Jofre-Monseny L, Minihane AM, Rimbach G (2008) Impact of apoE genotype on oxidative stress, inflammation and disease risk. Mol Nutr Food Res 52, 131-145.
22. Miyamoto M, Kodama C, Kinoshita T, Yamashita F, Hidaka S, Mizukami K, Kakuma T, Asada T (2009) Dementia and mild cognitive impairment among non-responders to a community survey. J Clin Neurosci 16, 270-276.
23. Yasuno F, Tanimukai S, Sasaki M, Hidaka S, Ikejima C, Yamashita F, Kodama C, Mizukami K, Michikawa M, Asada (2012) Association between cognitive function and plasma lipids of the elderly after controlling for apolipoprotein E genotype. Am J Geriatr Psychiatry 20, 574-583.
24. Yasuno F, Tanimukai S, Sasaki M, Ikejima C, Yamashita F, Kodama C, Hidaka S, Mizukami K, Asada T (2012) Effect of plasma lipids, hypertension and APOE genotype on cognitive decline. Neurobiol Aging, doi: 10. 1016/j. neurobiolaging. 2011. 12. 028.
25. Ryu KH, Han HY, Lee SY, Jeon SD, Im GJ, Lee BY, Kim K, Lim KM, Chung JH (2009) Ginkgo biloba extract enhances antiplatelet and antithrombotic effects of cilostazol without prolongation of bleeding time. Thromb Res 124, 328-334.
26. Kalmijn S, Launer LJ, Ott A, Witteman JC, Hofman A, Breteler MM (1997) Dietary fat intake and the risk of incident dementia in the Rotterdam Study. Ann Neurol 42, 776-782.
27. Wenham PR, Price WH, Blandell G (1991) Apolipoprotein E genotyping by one-stage PCR. Lancet 337, 1158-1159.
28. Yesavage JA, Brink TL, Rose TL, Lum O, Huang V, Adey M, Leirer VO (1982) Development and validation of a geriatric depression screening scale: A preliminary report. J Psychiatr Res 17, 37-49.
29. Sohlberg M, Mateer CA (1986) Attention process training manual. Association for Neuropsychological Research & Development, Washington.
30. Grober E, Buschke H, Crystal H, Bang S, Dresner R (1988) Screening for dementia by memory testing. Neurology 38, 900-903.
31. Solomon PR, Pendlebury WW (1998) Recognition of Alzheimer's disease: The 7 Minute Screen. Fam Med 30, 265-271.
32. Wechsler D (1981) WAIS-R: manual: Wechsler adult intelligence scale-revised, Harcourt Brace Jovanovich for Psychological Corp, New York.
33. Cohen J (1988) Statistical power analysis for the behavioural sciences. Lawrence Erlbaum, Hillsdale, NJ.
34. Gamoh S, Hashimoto M, Hossain S, Masumura S (2001) Chronic administration of docosahexaenoic acid improves the performance of radial arm maze task in aged rats. Clin Exp Pharmacol Physiol 28, 266-270.
35. Hashimoto M, Hossain S, Tanabe Y, Kawashima A, Harada T, Yano T, Mizuguchi K, Shido O (2009) The protective effect of dietary eicosapentaenoic acid against impairment of spatial cognition learning ability in rats infused with amyloid beta(1-40). J Nutr Biochem 20, 965-973.
36. Hashimoto M, Tanabe Y, Fujii Y, Kikuta T, Shibata H, ShidoO (2005) Chronic administration of docosahexaenoic acid ameliorates the impairment of spatial cognition learning ability in amyloid beta-infused rats. J Nutr 135, 549-555.
37. Lim GP, Calon F, Morihara T, Yang F, Teter B, Ubeda O, Salem NJ, Frautschy SA, Cole GM (2005) A diet enriched with the omega-3 fatty acid docosahexaenoic acid reduces amyloid burden in an aged Alzheimer mouse model. J Neurosci 25, 3032-3040.
38. Holub DJ, Holub BJ (2004) Omega-3 fatty acids from fish oils and cardiovascular disease. Mol Cell Biochem 263, 217-225.
39. He K, Song Y, Daviglus ML, Liu K, Van Horn L, Dyer AR, Goldbourt U, Greenland P (2004) Fish consumption and incidence of stroke: A meta-analysis of cohort studies. Stroke 35, 1538-1542.
40. Newman PE (2000) Alzheimer's disease revisited. Med Hypotheses 54, 774-776.
41. Porter NA, Caldwell SE, Mills KA (1995) Mechanisms of free radical oxidation of unsaturated lipids. Lipids 30, 277-290.
42. Kang JH, Grodstein F (2008) Plasma carotenoids and tocopherols and cognitive function:Aprospective study. Neurobiol Aging 29, 1394-1403.
43. Stahl W, Junghans A, de Boer B, Driomina ES, Briviba K, Sies H (1998) Carotenoid mixtures protect multilamellar liposomes against oxidative damage: Synergistic effects of lycopene and lutein. FEBS Lett 427, 305-308.
44. Mondraǵon-Rodŕguez S, Basurto-Islas G, Lee HG, Perry G, Zhu X, Castellani RJ, Smith MA (2010) Causes versus effects: The increasing complexities of Alzheimer's disease pathogenesis. Expert Rev Neurother 10, 683-691.
45. Rebeck GW, Reiter JS, Strickland DK, Hyman BT (1993) Apolipoprotein E in sporadic Alzheimer's disease: Allelic variation and receptor interactions. Neuron 11, 575-580.
46. Saunders AM, Strittmatter WJ, Schmechel D, George-Hyslop PH, Pericak-Vance MA, Joo SH, Rosi BL, Gusella JF, Crapper-MacLachlan DR, Alberts MJ (1993) Association of apolipoprotein E allele epsilon 4 with late-onset familial and sporadic Alzheimer's disease. Neurology 473, 1467-1472.
47. Strittmatter WJ, Saunders AM, Schmechel D, Pericak-Vance MA, Enghild J, Salvesen GS, Roses AD (1993) Apolipoprotein E: High-avidity binding to beta-amyloid and increased frequency of type 4 allele in late-onset familial Alzheimer disease. Proc Natl Acad Sci USA 90, 1977-1981.